Can we exploit the unusual expression pattern of the ELF3 gene to treat advanced prostate cancer?

In a nutshell

This is a study to find out if the gene ELF3 plays a role in prostate cancer aggressiveness. If significant, this gene could then be exploited as a new treatment target.

Why we funded it

Currently, advanced prostate cancer is difficult to treat and existing hormone therapies become ineffective over time. This study will give the researchers a greater understanding of the underlying biology of advanced prostate cancer and in turn help to identify a potential new treatment target.

Grant information

Researcher - Professor Norman Maitland
Institution - University of York
Grant award - £ 99,910.00
Reference - S13-016